RCSI has partnered with Head Diagnostics (Dublin, Ireland) on a clinical study to enhance the assessment and monitoring of Multiple Sclerosis (MS) through innovative technology.
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and